Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 7—July 2014
Research

Changes in Capsule and Drug Resistance of Pneumococci after Introduction of PCV7, Japan, 2010–2013

Naoko Chiba, Miyuki Morozumi, Michi Shouji, Takeaki Wajima, Satoshi Iwata, Kimiko UbukataComments to Author , and the Invasive Pneumococcal Diseases Surveillance Study Group
Author affiliations: Keio University School of Medicine, Tokyo, Japan (N. Chiba, M. Morozumi, S. Iwata, K. Ubukata); Kitasato University, Tokyo (N. Chiba, M. Morozumi, K. Ubukata); National Cancer Center Hospital, Tokyo (M. Shouji); Tokyo University of Pharmacy and Life Sciences, Tokyo (T. Wajima)

Main Article

Figure 1

Distribution of general hospitals participating in surveillance for invasive pneumococcal disease, Japan, April 2010–March 2013. Numbers in light gray circles show the number of the hospitals in each prefecture. Numbers in dark gray circles show the number of hospitals in Tokyo and Osaka.

Figure 1. Distribution of general hospitals participating in surveillance for invasive pneumococcal disease, Japan, April 2010–March 2013Numbers in light gray circles show the number of the hospitals in each prefectureNumbers in dark gray circles show the number of hospitals in Tokyo and Osaka.

Main Article

Page created: June 17, 2014
Page updated: June 17, 2014
Page reviewed: June 17, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external